Overview

IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis

Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils, their secreted cytokines (interleukin-4), and metabolism in human health and disease states such as obesity and insulin resistance.
Phase:
Early Phase 1
Details
Lead Sponsor:
Mayo Clinic